Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
**Approach:** Conceptual metaphor, with a human-outcome touch. **Palette:** D, bold color field. A single ripe strawberry sits at the center of a bright warm-yellow mustard seamless backdrop, photographed from a low three-quarter angle. A thin, clear glass caution-style barrier, a plain glass cloche cracked slightly open, partly covers it. The strawberry's seeds and glossy red skin are in sharp focus, with a tiny bead of juice catching a highlight. Beside it, a lone matte black dumbbell handle edges into frame, blurred, hinting at training. A small electric green leaf calyx on the berry provides the accent. Lighting is hard, directional studio light from the upper left, casting a crisp, defined shadow across the yellow surface. The mood is curious but cautious, clean and editorial, like a magazine health feature. No text, labels, or logos anywhere in the scene.
Longevity

200 mg Fisetin Cut Inflammation and Insulin Resistance in 12 Weeks—Best With Training

Lyra Voss · · 4 min read

The hook: a "senolytic" supplement gets a human test, but not the one you might expect

Fisetin, a plant flavonoid found in foods like strawberries, has built a reputation online as an anti-aging "senolytic" compound. A new randomized controlled trial in the Journal of the International Society of Sports Nutrition put it in front of 44 men with obesity. The headline result: 200 mg a day of fisetin was linked with lower inflammatory markers and better insulin resistance, and the biggest improvements showed up when it was paired with a 12-week training program.

One caveat first. This study did not measure senescent cells or any senolytic effect. It looked at inflammation and blood sugar control. Any "zombie cell clearing" story is outside what this paper tested.

What the researchers actually did

  • Design: 12-week, parallel-group randomized controlled trial
  • Participants: 44 adult men with obesity (BMI over 30 kg/m²)
  • Four arms:
    1. Control + placebo (CP)
    2. Fisetin alone, 200 mg/day (F)
    3. Training + placebo (TP)
    4. Training + fisetin (TF)
  • Training: Eight resistance exercises at 60% of one-rep max with active rest, followed by progressive aerobic bouts at 50–70% of maximum heart rate

The team measured plasma Maresin-1, IL-6, TNF-alpha, fasting blood glucose, insulin, and HOMA-IR, a standard estimate of insulin resistance. They took measurements before and after the 12 weeks.

Wait, what is Maresin-1?

Maresin-1 (MaR1) is a "specialized pro-resolving mediator." Most anti-inflammatory strategies try to turn inflammation down. Mediators like MaR1 help the body finish an inflammatory response and return to baseline. The authors note that human intervention data on MaR1 in obesity are scarce, which is part of why this trial is interesting.

The findings, section by section

Inflammation: fisetin moved the needle

Significant group-by-time interactions appeared for IL-6 and TNF-alpha (both p = 0.001). Specifically:

  • IL-6 fell in the fisetin-alone, training-placebo, and training-fisetin groups
  • TNF-alpha fell in all three active arms (F, TP, TF)

So fisetin alone was associated with lower inflammatory markers over 12 weeks, without any exercise program.

Maresin-1: this one looks like an exercise story

Here the picture is less flattering to the supplement. Maresin-1 rose in the training-placebo and training-fisetin groups (both p = 0.001). The abstract does not report an increase in the fisetin-only group. The overall interaction was significant (p = 0.034), but the data suggest exercise drove the MaR1 change. The authors still frame the combination as improving "inflammatory resolution," so read that claim with some nuance.

Insulin resistance: the standout result

Fasting glucose, insulin, and HOMA-IR all fell significantly in every active arm (p = 0.003), with interaction effects at p = 0.001. The greatest reductions were in the training-plus-fisetin group. The authors conclude that the combination is a promising non-pharmacological strategy for reducing obesity-related metabolic risk.

The abstract does not give effect sizes or say whether the training-fisetin group differed significantly from training alone. "Greatest reductions" describes the direction of the result, not proof that fisetin adds a specific amount on top of exercise.

Practical takeaways

Dose used: 200 mg per day for 12 weeks. This is the only dose tested, so there is no evidence here about higher or lower amounts.

Timing: The abstract does not specify when during the day participants took it, or whether it was taken with food or around workouts. Do not read timing advice into this study.

Who it might be relevant to: The evidence applies to adult men with obesity who were also doing structured resistance-plus-aerobic training. If that is you, the study suggests the training itself is a strong lever, and that fisetin may add to it.

  • Women, lean people, and older or younger groups: none were studied
  • People with diabetes or on glucose-lowering drugs: the supplement was associated with lower glucose and insulin, so talk to your clinician before adding anything that could interact
  • Anyone pregnant, nursing, or on prescription medications: this trial offers no safety data for these groups
  • Anyone hoping for a proven anti-aging effect: this study didn't test that

Limitations worth knowing

  • Small sample: 44 men split across four groups leaves roughly 11 per arm if evenly divided, so findings can be fragile
  • Men only, with obesity: results may not apply to anyone else
  • Short duration: 12 weeks says nothing about long-term benefit or safety
  • Surrogate markers: blood markers changed, but the trial did not measure outcomes like diabetes onset, cardiovascular events, or body composition endpoints in this abstract
  • No senolytic measures: senescent-cell burden was not assessed
  • Mechanism is inferred: the "synergy" between exercise and fisetin's anti-inflammatory properties is the authors' interpretation, not something the design proves
  • Independent replication needed: a single trial is a starting point, not a verdict

The authors reported no conflicts of interest.

The bottom line

This randomized trial adds a human data point for a supplement that has mostly been discussed in preclinical terms. In men with obesity, 200 mg/day of fisetin was associated with lower IL-6, TNF-alpha, glucose, insulin, and HOMA-IR, and the strongest metabolic improvements came when fisetin was combined with interval resistance-aerobic training. Exercise alone also produced meaningful gains and was the clearer driver of Maresin-1. If you take one lesson from it, make it the training. Fisetin looks like a plausible add-on that needs larger, longer, more diverse trials before anyone calls it proven.

This article is for informational purposes and is not medical advice.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
LV

Written by

Lyra Voss

Lyra Voss writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette D, bold color field. A single old brass pocket watch, photographed from a slightly high three-quarter angle, sits on a saturated mustard-yellow seamless backdrop. The watch case is cracked open and its glass is gone. One half of the gear train is clean and polished. The other half is corroded, with a dull green-black patina. A few fine droplets of clear liquid sit on the corroded gears, and one tiny electric green (#00e676) glint of oxidation shows at the edge of the damage. Hard but slightly diffused studio strobe from the upper left casts a crisp, short shadow on the yellow. The macro lens gives a shallow depth of field, with the sharpest focus on the split between healthy and damaged gears. The mood is cautionary, precise and quietly unsettling. No text or numerals appear on the dial.
longevity

The Anti-Aging Compound Spermidine Has a Dark Side in Old T Cells

BY DR. SYNAPSE ·

Spermidine is widely promoted as an anti-aging polyamine, but a new mouse-derived cell study found it can sabotage a specific group of old immune cells. In senescence-like CD49d- CD8+ T cells, it cut mitochondrial respiration, depleted antioxidant reserves, and fragmented mitochondria, while neighboring CD49d+ cells were untouched. Cells from young mice responded differently, which makes age a key variable. This is preclinical work, not evidence of harm in humans, but it challenges the idea that spermidine helps every aging cell. Here's what the paper found and what it does and doesn't mean for you.
**Approach: Conceptual metaphor. Palette: D, bold color field.** A single analog wall clock with a blank white face and plain black hands, photographed straight-on against a saturated mustard-yellow backdrop. Its glass is slightly fogged. Several translucent multivitamin tablets, in the speckled orange-tan of a real multivitamin, rest on the clock's lower rim and in front of its face. One tablet is half-dissolved and leaves a faint haze on the glass. The clock hands sit just short of each other, hinting that the time barely shifted. Behind the clock a thin ghost shadow of a second clock hand falls a few degrees off, suggesting a nudge that isn't conclusive. A hair-thin electric green (#00e676) second hand adds a small accent. Soft, diffused studio light from the upper left creates gentle shadows on the yellow. The camera is at eye level with a shallow depth of field. The mood is wry and skeptical, curious but unconvinced.
longevity

A Cheap Multivitamin Nudged DHA Up—But the Aging Clocks Stayed Put

BY DR. SYNAPSE ·

Two years of a daily Centrum Silver gave older adults small bumps in DHA and omega-3 fatty acids and slowed the usual rise in creatinine, according to a COSMOS randomized trial analysis. Metabolomic risk scores for 16 chronic diseases also dipped, and all seven aging clocks trended 0.5 to 1.05 years younger. The twist is that none of it survived multiple-testing correction. Here is what the data show, what they don't, and who might care.
Approach: conceptual metaphor, with a natural palette. A single walnut is cracked open on a rough wooden board, and its two halves sit slightly apart. The halves are shot in tight macro from a low three-quarter angle. The walnut's brain-like folds are the focus. Between the halves, a thin cluster of fine, dark brown tannin-stained fibers stretches like a bridge. Beside it sits a small pile of shell fragments with a few strands of green walnut husk. A small, sharp, electric green (#00e676) leaf catches the light at the edge of the frame. The background is a softly blurred window-lit kitchen garden in leafy greens and warm earth tones. Soft natural daylight comes from the left and gives gentle shadows and visible texture on the nut's ridges. The mood is calm, curious and quietly scientific, with a fresh morning feel and no blue cast.
longevity

Urolithin A: The Walnut Gut Byproduct Tied to a Thicker Brain

BY NOVA CHEN ·

Eat a walnut and your gut bacteria turn its ellagitannins into urolithins, compounds that may be tied to how well your brain ages. In a 2-year MRI sub-study of the WAHA trial, bigger rises in urolithin A, urolithin C, and urolithin C glucuronide were associated with preserved cortical thickness among walnut eaters, mostly in right-hemisphere regions. The pattern was stronger in people with metabotype B gut profiles. But this is an association inside a randomized trial, not proof of cause, and it says nothing direct about urolithin A supplements. Here's what the data show, who might care, and who should stay skeptical.
**Approach: Conceptual metaphor. Palette: D, bold color field.** A single clear glass pipette dropper hangs just above a small glass dish on a saturated mustard-yellow seamless backdrop. One golden-amber droplet of oil falls from its tip, caught mid-air, with a faint ripple already spreading across the otherwise flat surface below. The dish is half-filled with clear fluid, a quiet nod to cerebrospinal fluid. The camera sits low and slightly off-axis, at a shallow 35° angle, with a macro lens and a softly blurred background. Large diffused studio light from the upper left gives crisp highlights on the glass and a clean, soft shadow on the yellow floor. A thin electric green reflection runs along the glass rim. The mood is sober and skeptical: a hopeful intervention producing a measurable ripple but no dramatic change. Photorealistic, with no text.
longevity

2 g of DHA a Day Reached the Brain in APOE4 Carriers, but Memory Did Not Budge

BY DR. SYNAPSE ·

A two-year trial gave older adults 2 grams of DHA a day. It moved a key marker in the fluid around the brain, but it did not change brain volumes or cognitive test performance. The study, published in EBioMedicine by Yassine and colleagues, tested the idea in people carrying the APOE ε4 gene variant and in people without it. It is one of the clearer reality checks the omega-3 field has had.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文